{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:08:34Z","timestamp":1794092914684,"version":"4.8.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-NTF-22-924702"],"award-info":[{"award-number":["AARG-NTF-22-924702"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-143140OB-I00"],"award-info":[{"award-number":["PID2022-143140OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-099200-B-I00"],"award-info":[{"award-number":["RTI2018-099200-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","award":["PERIS 2019 SLT008\/18\/00050"],"award-info":[{"award-number":["PERIS 2019 SLT008\/18\/00050"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PY20_00858"],"award-info":[{"award-number":["PY20_00858"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red sobre Enfermedades Neurodegenerativas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021SGR 00761"],"award-info":[{"award-number":["2021SGR 00761"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021SGR00990"],"award-info":[{"award-number":["2021SGR00990"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2020-119978RB-I00"],"award-info":[{"award-number":["PID2020-119978RB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["FI_B100153"],"award-info":[{"award-number":["FI_B100153"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.redox.2023.102772","type":"journal-article","created":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T09:44:44Z","timestamp":1685871884000},"page":"102772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Farida","family":"Dakterzada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Jov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Pi\u00f1oll-Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.102772_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.redox.2023.102772_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.redox.2023.102772_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","article-title":"Metabolomics of human brain aging and age-related neurodegenerative diseases","volume":"73","author":"Jov\u00e9","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2023.102772_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/ars.2021.0177","article-title":"Altered metabolism in Alzheimer disease brain: role of oxidative stress","volume":"36","author":"Rummel","year":"2022","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2023.102772_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-016-0342-y","article-title":"Environmental risk factors for dementia: a systematic review","volume":"16","author":"Killin","year":"2016","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.redox.2023.102772_bib6","article-title":"Hypothesis review: Alzheimer's overture guidelines","volume":"33","author":"Ferrer","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.redox.2023.102772_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/life11050388","article-title":"The causal role of lipoxidative damage in mitochondrial bioenergetic dysfunction linked to Alzheimer's disease pathology","volume":"11","author":"Jov\u00e9","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.redox.2023.102772_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.redox.2023.102772_bib9","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s12035-015-9143-0","article-title":"The essential role of soluble A\u03b2 oligomers in Alzheimer's disease","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2023.102772_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tins.2017.04.002","article-title":"Synaptic impairment in Alzheimer's disease: a dysregulated symphony","volume":"40","author":"Forner","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.redox.2023.102772_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fnins.2019.00735","article-title":"Targeting the synapse in Alzheimer's disease","volume":"13","author":"Jackson","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.redox.2023.102772_bib12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.redox.2023.102772_bib13","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/antiox11081511","article-title":"Oxidative stress as a potential mechanism underlying membrane hyperexcitability in neurodegenerative diseases","volume":"11","author":"Pardillo-D\u00edaz","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2023.102772_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102772_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178127","article-title":"Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells","volume":"12","author":"Muche","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2023.102772_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.redox.2023.102772_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2147\/JIR.S275595","article-title":"Reactive oxygen species: drivers of physiological and pathological processes","volume":"13","author":"Checa","year":"2020","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.redox.2023.102772_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.redox.2023.102772_bib19","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2023.102772_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102772_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1073\/pnas.98.1.69","article-title":"Glutamic and aminoadipic semialdehydes are the main carbonyl products of metal-catalyzed oxidation of proteins","volume":"98","author":"Requena","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2023.102772_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00726-003-0017-9","article-title":"Maillard reaction products in tissue proteins: new products and new perspectives","volume":"25","author":"Thorpe","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.redox.2023.102772_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101901","article-title":"Protein oxidation - formation mechanisms, detection and relevance as biomarkers in human diseases","volume":"42","author":"Kehm","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102772_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0197-4580(02)00086-6","article-title":"Pentosidine and N\u03b5-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia","volume":"24","author":"B\u00e4r","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.redox.2023.102772_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101546","article-title":"Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease","volume":"34","author":"Sharma","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.102772_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-181272","article-title":"Circulating and extracellular vesicles levels of N-(1-Carboxymethyl)-L-Lysine (CML) differentiate early to moderate Alzheimer's disease","volume":"69","author":"Haddad","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.redox.2023.102772_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2023.102772_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1471-4159.2004.02864.x","article-title":"Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment","volume":"92","author":"Ahmed","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2023.102772_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1515\/cclm-2012-0829","article-title":"Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?","volume":"52","author":"Monacelli","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.redox.2023.102772_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10715760701861373","article-title":"Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment","volume":"42","author":"Bermejo","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2023.102772_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.redox.2023.102772_bib32","series-title":"Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR)","year":"2000"},{"key":"10.1016\/j.redox.2023.102772_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0000000000001209","article-title":"Mild cognitive impairment with suspected nonamyloid pathology (SNAP): prediction of progression","volume":"84","author":"Caroli","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.redox.2023.102772_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1874609812666190112095430","article-title":"Usefulness of CSF biomarkers in predicting the progression of Amnesic and nonamnesic mild cognitive impairment to Alzheimer's disease","volume":"12","author":"Ortega","year":"2019","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.redox.2023.102772_bib35","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1074\/jbc.M502255200","article-title":"Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets","volume":"280","author":"Pamplona","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.102772_bib36","series-title":"Regression Analysis","author":"Rudolf","year":"2006"},{"key":"10.1016\/j.redox.2023.102772_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00401-002-0523-y","article-title":"Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease","volume":"104","author":"Dei","year":"2002","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2023.102772_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2005.12.017","article-title":"Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment","volume":"397","author":"Butterfield","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.redox.2023.102772_bib39","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2010.02.016","article-title":"Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer's disease (PCAD)","volume":"48","author":"Bradley","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102772_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/bbrc.1997.6944","article-title":"Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons","volume":"236","author":"Horie","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2023.102772_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s004010050839","article-title":"Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain","volume":"95","author":"Takeda","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2023.102772_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s004010000256","article-title":"Neuronal and glial advanced glycation end product [N\u03b5-(carboxymethyl)lysine] in Alzheimer's disease brains","volume":"101","author":"Takeda","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.redox.2023.102772_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.freeradbiomed.2017.12.016","article-title":"Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: a meta-analysis in human pathological specimens","volume":"115","author":"Zabel","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2023.102772_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2009.00326.x","article-title":"Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates","volume":"20","author":"Mart\u00ednez","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.redox.2023.102772_bib45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-\u03b2 deposition in down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2023.102772_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.jnen.0000228136.58062.bf","article-title":"Involvement of oxidative stress in Alzheimer disease","volume":"65","author":"Nunomura","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.redox.2023.102772_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer's disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2023.102772_bib48","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/jcm8060840","article-title":"Salivary redox biomarkers in different stages of dementia severity","volume":"8","author":"Klimiuk","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.redox.2023.102772_bib49","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/ijms18102205","article-title":"Antioxidant defence, oxidative stress and oxidative damage in saliva, plasma and erythrocytes of dementia patients. Can salivary AGE be a marker of dementia?","volume":"18","author":"Choroma\u0144ska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2023.102772_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11357-007-9042-z","article-title":"Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects","volume":"30","author":"Su","year":"2008","journal-title":"Age (Dordr)."},{"key":"10.1016\/j.redox.2023.102772_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2013.07.005","article-title":"Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis","volume":"59","author":"Schrag","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2023.102772_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101639","article-title":"Oxidative stress and antioxidant defenses in mild cognitive impairment: a systematic review and meta-analysis","volume":"79","author":"Nantachai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.redox.2023.102772_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104795","article-title":"Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease","volume":"138","author":"Butterfield","year":"2020","journal-title":"Neurobiol. Dis."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:31:39Z","timestamp":1761978699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":53,"alternative-id":["S2213231723001738"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.102772","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.102772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102772"}}